{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:40:28Z","timestamp":1780926028085,"version":"3.54.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Heterotopic ossification (HO) occurs following orthopedic trauma, spinal cord injuries, brain trauma and limb amputations. Once symptomatic, HO causes pain, limited mobility and decreased quality of life. Current treatments are limited and have significant complications with high recurrence rates, underscoring the need for improved therapeutic interventions. Osteoclasts (OCs) are physiological bone resorptive cells that secrete enzymes and protons to degrade bone.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we describe the use of genetically engineered OCs as a novel cell therapy approach to treat HO. Inducible, engineered myeloid precursors (iRANK cells) treated with a chemical inducer of dimerization (CID) differentiated into TRAP<jats:sup>+<\/jats:sup> multinucleated OCs and resorbed mineralized tissues <jats:italic>in vitro<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p><jats:italic>In vivo<\/jats:italic>, BMP-2-induced murine HO lesions were significantly regressed following treatment using iRANK cells with concomitant systemic administration of CID. Moreover, many OCs were TRAP<jats:sup>+<\/jats:sup>, MMP9<jats:sup>+<\/jats:sup>, and GFP<jats:sup>+<\/jats:sup>, indicating that they differentiated from delivered iRANK cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>In summary, these data con rm the ability of engineered myeloid precursors to differentiate into OCs and resorb HO <jats:italic>in vivo<\/jats:italic> paving the way for OC delivery as a promising approach for HO treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fbioe.2024.1491962","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T04:48:25Z","timestamp":1732250905000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Engineered myeloid precursors differentiate into osteoclasts and resorb heterotopic ossification in mice"],"prefix":"10.3389","volume":"12","author":[{"given":"Cameron","family":"Rementer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apichai","family":"Yavirach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Worakanya","family":"Buranaphatthana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Walczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Speer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kat","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramanian","family":"Dharmarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Leber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Sangiorzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Bain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Scatena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Bl\u00fcmke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia M.","family":"Giachelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"799","DOI":"10.5966\/SCTM.2015-0365","article-title":"Surgical excision of heterotopic ossification leads to Re-emergence of mesenchymal stem cell populations responsible for recurrence","volume":"6","author":"Agarwal","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1007\/S11999-015-4271-4","article-title":"Botulinum toxin-induced muscle paralysis inhibits heterotopic bone formation","volume":"473","author":"Ausk","year":"2015","journal-title":"Clin. Orthop. Relat. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/S13287-023-03547-6","article-title":"Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins","volume":"14","author":"Bl\u00fcmke","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e66527","DOI":"10.3791\/66527","article-title":"Differentiation and characterization of osteoclasts from human induced pluripotent stem cells","volume":"2024","author":"Bl\u00fcmke","year":"2024","journal-title":"JoVE J. Vis. Exp."},{"key":"B5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/16501970510027628","article-title":"Heterotopic ossification: a review","volume":"37","author":"Bossche","year":"2005","journal-title":"J. Rehabil. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"116144","DOI":"10.1016\/J.BONE.2021.116144","article-title":"Engineered osteoclasts resorb necrotic alveolar bone in anti-RANKL antibody-treated mice","volume":"153","author":"Buranaphatthana","year":"2021","journal-title":"Bone"},{"key":"B7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3390\/BIOMEDICINES8120611","article-title":"Genetic and acquired heterotopic ossification: a translational tale of mice and men","volume":"8","author":"Cappato","year":"2020","journal-title":"Biomedicines"},{"key":"B8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1691\/ph.2012.1802","article-title":"Effects of tetracyclines on bones: an ambiguous question needs to be clarified","volume":"67","author":"Cheng","year":"2012","journal-title":"Pharmazie"},{"key":"B9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-1-61779-415-5_13","article-title":"RANKL-mediated osteoclast formation from murine RAW 264.7 cells","volume":"816","author":"Collin-Osdoby","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e95083","DOI":"10.7554\/ELIFE.95083","article-title":"Current perspectives on the multiple roles of osteoclasts: mechanisms of osteoclast\u2013osteoblast communication and potential clinical implications","volume":"13","author":"Daponte","year":"2024","journal-title":"Elife"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e355","DOI":"10.1002\/TERM.2320","article-title":"PDGF is a potent initiator of bone formation in a tissue engineered model of pathological ossification","volume":"12","author":"Davies","year":"2018","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"B12","first-page":"201","article-title":"Osteoclasts: malefactors of disease and targets for treatment","volume":"13","author":"Edwards","year":"2012","journal-title":"Discov. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"842090","DOI":"10.3389\/fncel.2022.842090","article-title":"Impact of heterotopic ossification on functional recovery in acute spinal cord injury","volume":"16","author":"Franz","year":"2022","journal-title":"Front. Cell Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/01.res.0000161997.24797.c0","article-title":"Regulation of vascular calcification: roles of phosphate and osteopontin","volume":"96","author":"Giachelli","year":"2005","journal-title":"Circ. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1177\/00912700122010771","article-title":"Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903, in healthy volunteers","volume":"41","author":"Iuliucci","year":"2001","journal-title":"J. Clin. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"6327","DOI":"10.1038\/s41467-021-26593-1","article-title":"Engineered osteoclasts as living treatment materials for heterotopic ossification therapy","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"20197","DOI":"10.1074\/jbc.M909174199","article-title":"Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification","volume":"275","author":"Jono","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"115765","DOI":"10.1016\/J.BONE.2020.115765","article-title":"A review of the biomarkers and in vivo models for the diagnosis and treatment of heterotopic ossification following blast and trauma-induced injuries","volume":"143","author":"Kazezian","year":"2021","journal-title":"Bone"},{"key":"B19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1247\/CSF.08039","article-title":"Ectopic calcification is caused by elevated levels of serum inorganic phosphate in mdx mice","volume":"34","author":"Kikkawa","year":"2009","journal-title":"Cell Struct. Funct."},{"key":"B20","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/PMIC.200300410","article-title":"Proteome analysis of secreted proteins during osteoclast differentiation using two different methods: two-dimensional electrophoresis and isotope-coded affinity tags analysis with two-dimensional chromatography","volume":"3","author":"Kubota","year":"2003","journal-title":"Proteomics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.4049\/JIMMUNOL.175.5.3015","article-title":"Activation of vascular endothelial growth factor receptor-2 in bone marrow leads to accumulation of myeloid cells: role of granulocyte-macrophage colony-stimulating factor","volume":"175","author":"Larriv\u00e9e","year":"2005","journal-title":"J. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/1440-1681.13025","article-title":"Challenges of heterotopic ossification\u2014molecular background and current treatment strategies","volume":"45","author":"\u0141\u0119gosz","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/3860142","article-title":"Heterotopic ossification: a challenging complication of total hip arthroplasty: risk factors, diagnosis, prophylaxis, and treatment","volume":"2019","author":"\u0141\u0229gosz","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"B24","doi-asserted-by":"publisher","first-page":"7268","DOI":"10.1021\/JF1047578","article-title":"Investigation of sulfonamide, tetracycline, and quinolone antibiotics in vegetable farmland soil in the pearl river delta area, southern China","volume":"59","author":"Li","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1161\/01.RES.74.2.214","article-title":"Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro","volume":"74","author":"Liaw","year":"1994","journal-title":"Circ. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"886579","DOI":"10.3389\/fbioe.2022.886579","article-title":"Assessment of strategies for safe drug discontinuation and transition of denosumab treatment in PMO\u2014insights from a mechanistic PK\/PD model of bone turnover","volume":"10","author":"Mart\u00ednez-Reina","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1682\/JRRD.2010.03.0033","article-title":"Heterotopic ossification in combat amputees from Afghanistan and Iraq wars: five case histories and results from a small series of patients","volume":"48","author":"Melcer","year":"2011","journal-title":"J. Rehabil. Res. Dev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/JBM.B.35207","article-title":"Effect of simulated body fluid formulation on orthopedic device apatite-forming ability assessment","volume":"111","author":"Nguyen","year":"2023","journal-title":"J. Biomed. Mater Res. B Appl. Biomater."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/mt.2011.8","article-title":"Long-term regulation of genetically modified primary hematopoietic cells in dogs","volume":"19","author":"Okazuka","year":"2011","journal-title":"Mol. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3389\/fbioe.2018.00134","article-title":"In vitro models of bone remodelling and associated disorders","volume":"6","author":"Owen","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e84465","DOI":"10.1371\/JOURNAL.PONE.0084465","article-title":"An inducible, ligand-independent receptor activator of NF-\u03baB gene to control osteoclast differentiation from monocytic precursors","volume":"8","author":"Rementer","year":"2013","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1006\/BBRC.1998.9306","article-title":"Detection of mouse osteopontin by western blotting","volume":"250","author":"Rittling","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12859-017-1934-z","article-title":"ImageJ2: ImageJ for the next generation of scientific image data","volume":"18","author":"Rueden","year":"2017","journal-title":"BMC Bioinforma."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw - 2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1161\/atvbaha.107.144824","article-title":"Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease","volume":"27","author":"Scatena","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/S0002-9440(10)64482-3","article-title":"Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification","volume":"161","author":"Steitz","year":"2002","journal-title":"Am. J. Pathology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"981372","DOI":"10.3389\/fped.2022.981372","article-title":"Fibrodysplasia ossificans progressiva: a rare disease with spinal deformity and severe hip dysfunction","volume":"10","author":"Sun","year":"2022","journal-title":"Front. Pediatr."},{"key":"B39","doi-asserted-by":"publisher","first-page":"754205","DOI":"10.3389\/fbioe.2021.754205","article-title":"Incorporation of bone morphogenetic protein-2 and osteoprotegerin in 3D-printed Ti6Al4V scaffolds enhances osseointegration under osteoporotic conditions","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/J.BONE.2017.08.025","article-title":"Heterotopic ossification: mechanistic insights and clinical challenges","volume":"109","author":"Xu","year":"2018","journal-title":"Bone"},{"key":"B41","doi-asserted-by":"publisher","first-page":"770931","DOI":"10.3389\/fcell.2022.770931","article-title":"Heterotopic ossification: clinical features, basic researches, and mechanical stimulations","volume":"10","author":"Xu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1326977","DOI":"10.3389\/FSURG.2024.1326977","article-title":"A young woman with atypical McCune\u2013Albright syndrome and the difficult road to recovery: a case report","volume":"11","author":"Zheng","year":"2024","journal-title":"Front. Surg."}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2024.1491962\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T04:48:29Z","timestamp":1732250909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2024.1491962\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":41,"alternative-id":["10.3389\/fbioe.2024.1491962"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2024.1491962","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"article-number":"1491962"}}